IL155574A0 - Treatment of pcp addiction and pcp addiction-related behavior - Google Patents

Treatment of pcp addiction and pcp addiction-related behavior

Info

Publication number
IL155574A0
IL155574A0 IL15557401A IL15557401A IL155574A0 IL 155574 A0 IL155574 A0 IL 155574A0 IL 15557401 A IL15557401 A IL 15557401A IL 15557401 A IL15557401 A IL 15557401A IL 155574 A0 IL155574 A0 IL 155574A0
Authority
IL
Israel
Prior art keywords
pcp addiction
treatment
pcp
addiction
related behavior
Prior art date
Application number
IL15557401A
Other languages
English (en)
Original Assignee
Brookhaven Science Ass Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brookhaven Science Ass Llc filed Critical Brookhaven Science Ass Llc
Publication of IL155574A0 publication Critical patent/IL155574A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/041—Heterocyclic compounds
    • A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K51/0446—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Addiction (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
IL15557401A 2000-10-23 2001-03-07 Treatment of pcp addiction and pcp addiction-related behavior IL155574A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/694,040 US6395783B1 (en) 2000-10-23 2000-10-23 Treatment of PCP addiction and PCP addiction-related behavior
PCT/US2001/007233 WO2002034249A1 (en) 2000-10-23 2001-03-07 Treatment of pcp addiction and pcp addiction-related behavior

Publications (1)

Publication Number Publication Date
IL155574A0 true IL155574A0 (en) 2003-11-23

Family

ID=24787164

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15557401A IL155574A0 (en) 2000-10-23 2001-03-07 Treatment of pcp addiction and pcp addiction-related behavior
IL155574A IL155574A (en) 2000-10-23 2003-04-24 Use of Gamma Vinyl GABA for the Preparation of a Drug for the Treatment of PCP Addiction and Behavior Related to This Addiction

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL155574A IL155574A (en) 2000-10-23 2003-04-24 Use of Gamma Vinyl GABA for the Preparation of a Drug for the Treatment of PCP Addiction and Behavior Related to This Addiction

Country Status (17)

Country Link
US (1) US6395783B1 (https=)
EP (1) EP1335717A4 (https=)
JP (1) JP2004512301A (https=)
KR (1) KR20030074610A (https=)
CN (2) CN1234352C (https=)
AU (2) AU4201101A (https=)
BR (1) BR0114898A (https=)
CA (1) CA2426210C (https=)
CZ (1) CZ20031431A3 (https=)
HR (1) HRP20030322A2 (https=)
HU (1) HUP0301441A3 (https=)
IL (2) IL155574A0 (https=)
MX (1) MXPA03003589A (https=)
NO (1) NO20031814L (https=)
NZ (1) NZ526072A (https=)
PL (1) PL361028A1 (https=)
WO (1) WO2002034249A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
CN114903006B (zh) * 2021-02-09 2024-08-02 中国科学院脑科学与智能技术卓越创新中心 一种非人灵长类动物物质成瘾模型的构建方法与应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2133002B (en) 1982-12-30 1986-01-29 Merrell Toraude & Co Process for preparing 4-amino-5-hexenoic acid
GB8311804D0 (en) 1983-04-29 1983-06-02 Merrell Toraude & Co Treatment of seizure disorders and pharmaceutical compositions
US4595697A (en) 1984-03-28 1986-06-17 Merrell Dow Pharmaceuticals Inc. Treatment of seizure disorders and pharmaceutical compositions useful therein
US5189064A (en) 1985-07-22 1993-02-23 Matrix Technologies, Inc. Treatment of cocaine addiction
JPH03500411A (ja) 1987-10-07 1991-01-31 マトリックス　テクノロジーズ　インコーポレーテッド コカイン中毒の処置および治療薬
US5102913A (en) * 1991-07-01 1992-04-07 Halikas James A Treatment for cocaine use employing valproic acid
KR20010031470A (ko) 1997-10-28 2001-04-16 둘락 노먼 씨. 포유동물의 갈망을 감소시키는 방법
US6541520B1 (en) * 1998-08-05 2003-04-01 Brookhaven Science Associates Treatment of addiction and addiction-related behavior
CN100548290C (zh) 1999-02-24 2009-10-14 辛辛那提大学 氨基磺酸酯衍生物用于治疗冲动控制障碍的用途

Also Published As

Publication number Publication date
JP2004512301A (ja) 2004-04-22
WO2002034249A1 (en) 2002-05-02
CN1476326A (zh) 2004-02-18
KR20030074610A (ko) 2003-09-19
CZ20031431A3 (cs) 2004-06-16
HUP0301441A3 (en) 2011-07-28
AU2001242011B2 (en) 2005-11-03
BR0114898A (pt) 2003-08-12
NZ526072A (en) 2004-08-27
CN1234352C (zh) 2006-01-04
CA2426210C (en) 2009-12-22
CN1771929A (zh) 2006-05-17
PL361028A1 (en) 2004-09-20
MXPA03003589A (es) 2005-08-16
CA2426210A1 (en) 2002-05-02
HRP20030322A2 (en) 2005-02-28
NO20031814L (no) 2003-06-19
EP1335717A1 (en) 2003-08-20
AU4201101A (en) 2002-05-06
EP1335717A4 (en) 2004-06-30
AU2001242011B8 (en) 2006-03-02
HUP0301441A2 (hu) 2003-11-28
US6395783B1 (en) 2002-05-28
IL155574A (en) 2010-02-17
NO20031814D0 (no) 2003-04-23

Similar Documents

Publication Publication Date Title
HUP0103377A3 (en) Treatment of addiction and addiction-related behavior
AU7593001A (en) Alpha-msh related compounds and methods of use
AU1166502A (en) Human ect2 and methods of use
AU6118001A (en) Combination therapeutic compositions and methods of use
GB0111872D0 (en) Therapeutic agents and methods
EP1549614A4 (en) VASCULATORY AGENTS AND METHODS FOR THEIR APPLICATION
EP1385434A4 (en) TREATMENT OF CERVICAL EPROLAPS
IL213240A0 (en) Method of treatment using lighnd-immunogen conjugates
GB0210645D0 (en) Underreamer and method of use
EP1487538A4 (en) SEHPROTHESIS WITH IMPROVED RECEPTION AND STIMULATION PART
AU4976001A (en) Mucin-1 specific binding members and methods of use thereof
GB2362070B (en) Communication devices and method of communication
GB0010983D0 (en) Communication devices and method of communication
GB0022710D0 (en) Dispenser and method of use
AU1334602A (en) Osteopontin-coated surfaces and methods of use
AU2003277265A8 (en) Punctum dilating and punctum plug insertion instrument
IL151589A0 (en) New combination of a betablocker and a cholestrol-lowering agent
AU2002324895A8 (en) Cosmetic kit and method
AU5000001A (en) Treatment of vitiligo
AU2002363938A8 (en) Methods and use of motoneuronotropic factors
AU4201101A (en) Treatment of pcp addiction and pcp addiction-related behavior
AUPQ582400A0 (en) A method of treatment and agents for use therein
SG90719A1 (en) Novel therapeutic and prophylactic agents and methods of using same
GB0011573D0 (en) Oil and gas well stimulation
EP1392460A4 (en) AMINOSILANOL HYDROFLUORIDES AND THEIR USE